CHDI Management provides management services to CHDI Foundation and other non-profit organizations engaged in Huntington's disease research. CHDI operates as a not-for-profit "virtual biotech," collaborating with, and supporting a worldwide network of nearly 500 scientists in academic and industrial laboratories. Its activities extend from exploratory biology to the identification and validation of therapeutic targets, and from drug discovery and development to clinical studies and trials. CHDI also organize workshops and meetings, and make reagents and other research tools available to the Huntington's disease research community.
Mr. Blumenstein began his career as a lawyer at Torys, a law firm in Toronto, before moving into merchant banking, where he was responsible for structuring and negotiating transactions and supervising investment analysis. Mr. Blumenstein was a principal at First City Capital Corporation, CIBC Capital Partners and MMC Capital. Before all that, when he was still a kid, he built a harpsichord and was a director of Life Times Nine, a short subject film that was nominated for an Academy Award in 1973.
Mr. Blumenstein graduated from the University of Toronto with a BA (1975) and an LLB (1978), and has an MBA from Harvard Business School (1984).
Last Modified January 24, 2012